Meditera Tibbi Malzeme Sanayi ve Ticaret AS Asset Resilience Ratio

Latest as of March 2026: 1.26%

Meditera Tibbi Malzeme Sanayi ve Ticaret AS asset resilience ratio. Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has an Asset Resilience Ratio of 1.26% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Meditera Tibbi Malzeme Sanayi ve Ticaret to measure how many days the company can operate on defensive assets alone.

Liquid Assets

TL48.02 Million

≈ $1.08 Million USD Cash + Short-term Investments

Total Assets

TL3.82 Billion

≈ $85.56 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2021–2025)

Asset resilience ratio of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2021 to 2025. This chart shows how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's Asset Resilience Ratio has changed over time. Read MEDTR total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Meditera Tibbi Malzeme Sanayi ve Ticaret AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Meditera Tibbi Malzeme Sanayi ve Ticaret.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	TL0.00	0%
Short-term Investments	TL48.02 Million	1.26%
Total Liquid Assets	TL48.02 Million	1.26%

Asset Resilience Insights

Limited Liquidity: Meditera Tibbi Malzeme Sanayi ve Ticaret AS maintains only 1.26% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Industry Peers by Asset Resilience Ratio

Compare Meditera Tibbi Malzeme Sanayi ve Ticaret AS's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Vitrolife AB ST:VITR	Medical Devices	7.27%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Shanghai Sanyou Medical Co Ltd SHG:688085	Medical Devices	7.69%
Zhejiang Orient Gene Biotech Co Ltd SHG:688298	Medical Devices	2.82%
Nanjing Vishee Medical Technology Co Ltd SHG:688580	Medical Devices	10.74%
TAIDOC TECHNOLOGY CORP TW:4736	Medical Devices	23.03%
Dirui Industrial Co Ltd SHE:300396	Medical Devices	3.90%

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Asset Resilience Ratio by Year (2021–2025)

Meditera Tibbi Malzeme Sanayi ve Ticaret AS asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Meditera Tibbi Malzeme Sanayi ve Ticaret AS.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.96%	TL70.46 Million ≈ $1.58 Million	TL3.59 Billion ≈ $80.42 Million	-2.73pp
2024-12-31	4.69%	TL172.55 Million ≈ $3.86 Million	TL3.68 Billion ≈ $82.38 Million	-9.84pp
2023-12-31	14.53%	TL397.22 Million ≈ $8.90 Million	TL2.73 Billion ≈ $61.21 Million	-9.67pp
2022-12-31	24.20%	TL266.08 Million ≈ $5.96 Million	TL1.10 Billion ≈ $24.63 Million	+5.67pp
2021-12-31	18.53%	TL133.29 Million ≈ $2.99 Million	TL719.21 Million ≈ $16.11 Million	--

pp = percentage points

About Meditera Tibbi Malzeme Sanayi ve Ticaret AS

IS:MEDTR Turkey Medical Devices

Market Cap

$38.78 Million

TL1.73 Billion TRY

Market Cap Rank

#22582 Global

#322 in Turkey

Share Price

TL18.25

Change (1 day)

+1.39%

52-Week Range

TL16.96 - TL32.70

All Time High

TL52.90